Suppr超能文献

非霍奇金淋巴瘤患者化疗期间淋巴细胞亚群的监测。

The monitoring of lymphocyte subpopulations in non Hodgkin lymphoma patients during chemotherapy.

作者信息

Hołowiecki J, Japa J, Krawczyk-Kuliś M, Stella-Hołowiecka B, Rudzka E, Jarczok K, Kamińska H

出版信息

Arch Immunol Ther Exp (Warsz). 1978;26(1-6):837-43.

PMID:312089
Abstract

Numerous examinations of the changes in B, T, null subpopulations were systematically carried out in 20 non Hodgkin lymphoma patients 8, 24, 48 hours after the therapy onset and subsequently at intervals of a few days during and after each chemotherapy cycle (COP, Knospe). T cells were evaluated by examining the receptor for neuraminidase pretreated sheep erythrocytes (nE), B lymphocytes by detecting surface immunoglobulins (SmIg) with normal and Fc deprived anti Fab2 globulin, moreover receptors for mouse erythrocytes (Em) and for C3 (EAC) were examined. A characteristic rise of the dominating subpopulation was observed during the first phase of the drug application which, most probably, was due to an expulsion of the pathological cells from involved lymphatic organs to the blood. On the basis of our clinical observations a conclusion has been drown, that this type of monitoring possibly renders a maximal effective treatment, enables the control of the accompanying immunosuppression and offers an additional criterion of the remission.

摘要

对20例非霍奇金淋巴瘤患者在治疗开始后8小时、24小时、48小时,以及随后在每个化疗周期(COP方案、Knospe方案)期间及之后每隔几天,系统地进行了B细胞、T细胞、裸细胞亚群变化的多项检查。通过检测经神经氨酸酶预处理的绵羊红细胞(nE)受体评估T细胞,用正常和Fc剥夺的抗Fab2球蛋白检测表面免疫球蛋白(SmIg)评估B淋巴细胞,此外还检测了小鼠红细胞(Em)和C3(EAC)受体。在用药的第一阶段观察到占主导地位的亚群有特征性升高,这很可能是由于病变细胞从受累淋巴器官被驱赶到血液中。基于我们的临床观察得出结论,这种监测方式可能实现最大有效治疗,能够控制伴随的免疫抑制,并提供缓解的额外标准。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验